The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis

作者: Ying Wu , Hong-Bing Liu , Ming Ding , Jian-Nan Liu , Ping Zhan

DOI: 10.1007/S11033-012-1827-1

关键词:

摘要: E-cadherin has been implicated in invasiveness and metastasis. However, the clinical prognostic value of decreased expression patients with non-small cell lung cancer (NSCLC) remains unsettled. A meta-analysis eligible studies was performed to quantitatively review correlation survival NSCLC. Thirteen studies, including 2,274 patients, were subjected final analysis. The rate 47.6 % overall 41.4 for stage I disease. combined hazard ratio (HR) 1.41 (95 CI 0.18-1.65; P = 0.001), indicating that had an unfavorable impact on Further, stratified analysis by ethnicity, HR Asians 1.49 1.27-1.71) non-Asians 1.01 1.00-1.02). when only considered, 1.19 0.90-1.47; 0.576), suggesting no survival. Decreased associated poor NSCLC, especially among Asians, but not significantly correlated NSCLC patients.

参考文章(57)
Sanna M. Siitonen, Juha T. Kononen, Heikki J. Helin, Immo S. Rantala, Kaija A. Holli, Jorma J. Isola, Reduced E-Cadherin Expression is Associated With Invasiveness and Unfavorable Prognosis in Breast Cancer American Journal of Clinical Pathology. ,vol. 105, pp. 394- 402 ,(1996) , 10.1093/AJCP/105.4.394
Konstantinos Charalabopoulos, Setsuo Hirohashi, Antigony Mitselou, Theodoros Vougiouklakis, Yukihiro Nakanishi, Anna Batistatou, Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites. Histology and Histopathology. ,vol. 25, pp. 1257- 1267 ,(2010) , 10.14670/HH-25.1257
Theresa P. Pretlow, Thomas G. Pretlow, Saeid B. Amini, Moolky Nagabhushan, Liang Cheng, Expression of E-cadherin in primary and metastatic prostate cancer. American Journal of Pathology. ,vol. 148, pp. 1375- 1380 ,(1996)
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
Takeshi Hanagiri, Hidetaka Uramoto, Kenji Ono, Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC. Anticancer Research. ,vol. 30, pp. 3273- 3278 ,(2010)
M Paesmans, J P Sculier, P Libert, G Bureau, G Dabouis, J Thiriaux, J Michel, O Van Cutsem, R Sergysels, P Mommen, Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology. ,vol. 13, pp. 1221- 1230 ,(1995) , 10.1200/JCO.1995.13.5.1221
J Behrens, M M Mareel, F M Van Roy, W Birchmeier, Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. Journal of Cell Biology. ,vol. 108, pp. 2435- 2447 ,(1989) , 10.1083/JCB.108.6.2435
Salim Yusuf, Richard Peto, John Lewis, Rory Collins, Peter Sleight, Beta blockade during and after myocardial infarction: An overview of the randomized trials Progress in Cardiovascular Diseases. ,vol. 27, pp. 335- 371 ,(1985) , 10.1016/S0033-0620(85)80003-7
Ugo Cavallaro, Gerhard Christofori, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nature Reviews Cancer. ,vol. 4, pp. 118- 132 ,(2004) , 10.1038/NRC1276
R. M. Bremnes, R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, W. A. Franklin, High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 20, pp. 2417- 2428 ,(2002) , 10.1200/JCO.2002.08.159